Compare

Compare archived captures

This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.

Descriptive changes only

This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.

Need to cite this comparison? See /cite.

Compare to the live pageView snapshot

Earlier capture

Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca

Apr 18, 2025

legacy-hc-2025-04-21

ID 153411

Original URL ↗
View snapshot

Later capture

Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca

Apr 18, 2025

legacy-hc-2025-04-21

ID 164550

Original URL ↗
View snapshot
updatedArchived text updated
0 sections changed0 added0 removed+0 / -0 linesChange ratio: 0%

No diff is available for this capture pair. This can happen when content is unchanged or stored in a non-HTML format.